table of content
1 Introduction to Research & Analysis Reports
1.1 Engineered T Cells Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Engineered T Cells Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Engineered T Cells Overall Market Size
2.1 Global Engineered T Cells Market Size: 2021 VS 2028
2.2 Global Engineered T Cells Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Engineered T Cells Players in Global Market
3.2 Top Global Engineered T Cells Companies Ranked by Revenue
3.3 Global Engineered T Cells Revenue by Companies
3.4 Top 3 and Top 5 Engineered T Cells Companies in Global Market, by Revenue in 2021
3.5 Global Companies Engineered T Cells Product Type
3.6 Tier 1, Tier 2 and Tier 3 Engineered T Cells Players in Global Market
3.6.1 List of Global Tier 1 Engineered T Cells Companies
3.6.2 List of Global Tier 2 and Tier 3 Engineered T Cells Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Engineered T Cells Market Size Markets, 2021 & 2028
4.1.2 Tumor Infiltrating Lymphocytes
4.1.3 T Cell Receptor {TCR}
4.1.4 Chimeric Antigen Receptor(CAR)
4.2 By Type - Global Engineered T Cells Revenue & Forecasts
4.2.1 By Type - Global Engineered T Cells Revenue, 2017-2022
4.2.2 By Type - Global Engineered T Cells Revenue, 2023-2028
4.2.3 By Type - Global Engineered T Cells Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Engineered T Cells Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Cancer Research Centers
5.1.4 Clinics
5.2 By Application - Global Engineered T Cells Revenue & Forecasts
5.2.1 By Application - Global Engineered T Cells Revenue, 2017-2022
5.2.2 By Application - Global Engineered T Cells Revenue, 2023-2028
5.2.3 By Application - Global Engineered T Cells Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Engineered T Cells Market Size, 2021 & 2028
6.2 By Region - Global Engineered T Cells Revenue & Forecasts
6.2.1 By Region - Global Engineered T Cells Revenue, 2017-2022
6.2.2 By Region - Global Engineered T Cells Revenue, 2023-2028
6.2.3 By Region - Global Engineered T Cells Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Engineered T Cells Revenue, 2017-2028
6.3.2 US Engineered T Cells Market Size, 2017-2028
6.3.3 Canada Engineered T Cells Market Size, 2017-2028
6.3.4 Mexico Engineered T Cells Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Engineered T Cells Revenue, 2017-2028
6.4.2 Germany Engineered T Cells Market Size, 2017-2028
6.4.3 France Engineered T Cells Market Size, 2017-2028
6.4.4 U.K. Engineered T Cells Market Size, 2017-2028
6.4.5 Italy Engineered T Cells Market Size, 2017-2028
6.4.6 Russia Engineered T Cells Market Size, 2017-2028
6.4.7 Nordic Countries Engineered T Cells Market Size, 2017-2028
6.4.8 Benelux Engineered T Cells Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Engineered T Cells Revenue, 2017-2028
6.5.2 China Engineered T Cells Market Size, 2017-2028
6.5.3 Japan Engineered T Cells Market Size, 2017-2028
6.5.4 South Korea Engineered T Cells Market Size, 2017-2028
6.5.5 Southeast Asia Engineered T Cells Market Size, 2017-2028
6.5.6 India Engineered T Cells Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Engineered T Cells Revenue, 2017-2028
6.6.2 Brazil Engineered T Cells Market Size, 2017-2028
6.6.3 Argentina Engineered T Cells Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Engineered T Cells Revenue, 2017-2028
6.7.2 Turkey Engineered T Cells Market Size, 2017-2028
6.7.3 Israel Engineered T Cells Market Size, 2017-2028
6.7.4 Saudi Arabia Engineered T Cells Market Size, 2017-2028
6.7.5 UAE Engineered T Cells Market Size, 2017-2028
7 Players Profiles
7.1 Autolus Limited
7.1.1 Autolus Limited Corporate Summary
7.1.2 Autolus Limited Business Overview
7.1.3 Autolus Limited Engineered T Cells Major Product Offerings
7.1.4 Autolus Limited Engineered T Cells Revenue in Global Market (2017-2022)
7.1.5 Autolus Limited Key News
7.2 Bellicum Pharmaceuticals
7.2.1 Bellicum Pharmaceuticals Corporate Summary
7.2.2 Bellicum Pharmaceuticals Business Overview
7.2.3 Bellicum Pharmaceuticals Engineered T Cells Major Product Offerings
7.2.4 Bellicum Pharmaceuticals Engineered T Cells Revenue in Global Market (2017-2022)
7.2.5 Bellicum Pharmaceuticals Key News
7.3 Cells Medica
7.3.1 Cells Medica Corporate Summary
7.3.2 Cells Medica Business Overview
7.3.3 Cells Medica Engineered T Cells Major Product Offerings
7.3.4 Cells Medica Engineered T Cells Revenue in Global Market (2017-2022)
7.3.5 Cells Medica Key News
7.4 Elli Lilly and Company
7.4.1 Elli Lilly and Company Corporate Summary
7.4.2 Elli Lilly and Company Business Overview
7.4.3 Elli Lilly and Company Engineered T Cells Major Product Offerings
7.4.4 Elli Lilly and Company Engineered T Cells Revenue in Global Market (2017-2022)
7.4.5 Elli Lilly and Company Key News
7.5 Gilead Sciences
7.5.1 Gilead Sciences Corporate Summary
7.5.2 Gilead Sciences Business Overview
7.5.3 Gilead Sciences Engineered T Cells Major Product Offerings
7.5.4 Gilead Sciences Engineered T Cells Revenue in Global Market (2017-2022)
7.5.5 Gilead Sciences Key News
7.6 Juno Therapeutics
7.6.1 Juno Therapeutics Corporate Summary
7.6.2 Juno Therapeutics Business Overview
7.6.3 Juno Therapeutics Engineered T Cells Major Product Offerings
7.6.4 Juno Therapeutics Engineered T Cells Revenue in Global Market (2017-2022)
7.6.5 Juno Therapeutics Key News
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Engineered T Cells Major Product Offerings
7.7.4 Novartis Engineered T Cells Revenue in Global Market (2017-2022)
7.7.5 Novartis Key News
7.8 Oxford Biomedica
7.8.1 Oxford Biomedica Corporate Summary
7.8.2 Oxford Biomedica Business Overview
7.8.3 Oxford Biomedica Engineered T Cells Major Product Offerings
7.8.4 Oxford Biomedica Engineered T Cells Revenue in Global Market (2017-2022)
7.8.5 Oxford Biomedica Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Engineered T Cells Major Product Offerings
7.9.4 Pfizer Engineered T Cells Revenue in Global Market (2017-2022)
7.9.5 Pfizer Key News
7.10 Precision Bioscience
7.10.1 Precision Bioscience Corporate Summary
7.10.2 Precision Bioscience Business Overview
7.10.3 Precision Bioscience Engineered T Cells Major Product Offerings
7.10.4 Precision Bioscience Engineered T Cells Revenue in Global Market (2017-2022)
7.10.5 Precision Bioscience Key News
7.11 Redmile Group
7.11.1 Redmile Group Corporate Summary
7.11.2 Redmile Group Business Overview
7.11.3 Redmile Group Engineered T Cells Major Product Offerings
7.11.4 Redmile Group Engineered T Cells Revenue in Global Market (2017-2022)
7.11.5 Redmile Group Key News
7.12 Seeking Alpha
7.12.1 Seeking Alpha Corporate Summary
7.12.2 Seeking Alpha Business Overview
7.12.3 Seeking Alpha Engineered T Cells Major Product Offerings
7.12.4 Seeking Alpha Engineered T Cells Revenue in Global Market (2017-2022)
7.12.5 Seeking Alpha Key News
7.13 Unum Therapeutics
7.13.1 Unum Therapeutics Corporate Summary
7.13.2 Unum Therapeutics Business Overview
7.13.3 Unum Therapeutics Engineered T Cells Major Product Offerings
7.13.4 Unum Therapeutics Engineered T Cells Revenue in Global Market (2017-2022)
7.13.5 Unum Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
